Tech Innovations: June 2021 23-Jun-2021 By Jenni Spinner This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.
Evonik launches Resomer Precise custom functional excipients 15-Jun-2020 By Jenni Spinner The company reportedly is harnessing sophisticated technology to enable process validation of polymers to tight specifications in parenteral drugs.
Evonik invests in Japanese silica capacity 08-Sep-2014 By Dan Stanton Chemicals firm Evonik has expanded its capacity in Japan to cope with high demands for specialty silica, used in various drugmaking operations.
Evonik ups HPAPI capability in Germany and US as oncology market grows 11-Nov-2013 By Dan Stanton Evonik has upped its capabilities in highly potent active pharmaceutical ingredients (HPAPI) citing the increased market growth of oncology drugs.
Evonik to buy SurModics’ drug delivery assets and cGMP plant Evonik to buy SurModics’ drug delivery assets and cGMP plant 02-Nov-2011 By Nick Taylor SurModics is selling its drug delivery assets and cGMP manufacturing facility to Evonik for $30m (€22m) in cash.
Evonik strengthens metal catalyst ops in India and China Evonik strengthens metal catalyst ops in India and China 15-Jun-2010 By Nick Taylor Evonik has strengthened its precious metal powder catalysts business, opening a production site in Shanghai, China and buying an Indian company.
Lilly sells Tippecanoe API site to Evonik Lilly sells Tippecanoe API site to Evonik 15-Oct-2009 US drugmaker Eli Lilly will sell its Tippecanoe laboratories API manufacturing unit to Germany’s Evonik Industries.
